We are accelerating antibody drug development.
Sarada Sai Srinivasa Lakshman Rupanagunta
University of Groningen
Master of Science in Biomedical Engineering
Over het initiatief / About the initiative
In welke fase zit jouw initiatief? / In what stage is your initiative?
Heb je jouw initiatief al gevalideerd? / Did you validate your initiative?
Meer informatie over jouw initiatief / More info about your initiative
Antibody drugs are a class of drugs that have been used to treat cancer, infectious and autoimmune diseases. The problem is that they are expensive and time-consuming to develop. We are developing a algorithm that reduces the time it takes to develop a new antibody drug.
Wat is er anders/nieuw aan jouw idee/oplossing t.o.v. bestaande oplossingen? / What is different/new about your idea/solution compared to existing solutions??
In existing solutions, a new antibody is ‘discovered’ from a library containing billions of antibodies. The problem is that you have to search through the library to find the drugs that work which can take years. What we do instead is design these drugs, which can then be tested, validated and then developed further.
Wat zijn jouw volgende stappen om het verder te ontwikkelen? / What are your next steps to develop the initiative?
The next step is to build and test our algorithm by doing a proof-of-concept study and show that our algorithm works.
Wat heb je nodig om (nog meer) impact te maken met dit initiatief? / What do you need to make (more) impact with this initiative?
What we need is validation for our idea from the customer, and funding to accelerate the development of the algorithm.